甲状腺癌脑转移患者预后因素:系统综述与荟萃分析
该系统综述与荟萃分析纳入24项研究共301例甲状腺癌脑转移患者,评估与脑转移特异性生存(BMS)相关的预后因素。多因素Cox模型显示,未分化癌、低分化癌、ECOG>1、多发脑转移及存在远处转移与BMS降低显著相关,而脑转移灶大小和部位与BMS无关。
要点
- 未分化甲状腺癌脑转移患者BMS显著更差(HR 3.3)。
- ECOG>1、多发脑转移及颅外远处转移均与BMS降低独立相关。
- 脑转移灶大小和解剖部位与BMS无显著关联。
核心结论
- 甲状腺癌脑转移患者生存预后差,BMS为18个月(CI 1.07至3.56)。
- 侵袭性病理亚型、体能状态差、多发脑转移及颅外远处转移是BMS降低的关键预后因素。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、Scopus、Embase和MEDLINE至2025年7月18日。
- 共纳入24项研究,包括301例甲状腺癌脑转移患者,采用多因素Cox比例风险模型估计HR。
主要发现
- 未分化甲状腺癌与BMS降低相关(HR 3.3;CI 1.06至10.3;p=0.04)。
- 低分化甲状腺癌与BMS降低相关(HR 1.95;CI 1.07至3.56;p=0.03)。
- ECOG>1与BMS降低相关(HR 2.62;CI 1.69至4.05;p<0.001)。
- 多发脑转移与BMS降低相关(HR 1.89;CI 1.24至2.89;p=0.004)。
- 存在远处转移与BMS降低相关(HR 1.97;CI 1.13至3.44;p=0.018)。
关键数值与推荐
- 脑转移灶大小和 anatomical location 与BMS无显著关联。
临床怎么用
- 对甲状腺癌脑转移患者应评估病理亚型、ECOG体能状态、脑转移数目及颅外转移情况以进行预后分层。
- 强调多学科协作和全身疾病控制对改善此类患者结局的重要性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Brain metastases from thyroid cancer (TC) are rare but signify an advanced stage of the disease with poor survival outcomes. This study aimed to identify prognostic factors associated with brain metastasis-specific survival (BMS) in patients with brain metastases from TC. Methods: A systematic review and meta-analysis were conducted. Data were extracted from studies retrieved from PubMed, Scopus, Embase, and MEDLINE up to July 18, 2025. A multivariable Cox proportional hazards model was used to estimate hazard ratios (HRs) for potential prognostic factors. Results: A total of 24 studies, including 301 patients with brain metastases from TC, were included. BMS was 18 months (confidence interval [CI], 1.07 to 3.56). Key prognostic factors associated with decreased BMS included anaplastic thyroid carcinoma (HR, 3.3; CI, 1.06 to 10.3; p = 0.04), poorly differentiated thyroid carcinoma (HR, 1.95; CI, 1.07 to 3.56; p = 0.03), poor performance status (Eastern Cooperative Oncology Group >1) (HR, 2.62; CI, 1.69 to 4.05; p < 0.001), multiple brain metastases (HR, 1.89; CI, 1.24 to 2.89; p = 0.004), and the presence of distant metastases (HR, 1.97; CI, 1.13 to 3.44; p = 0.018). Neither the size nor the anatomical location of brain metastases was significantly associated with BMS. Conclusions: Brain metastases from TC are associated with poor survival, with key prognostic factors including aggressive tumor subtypes, poor performance status, multiple brain metastases, and the presence of extracranial metastases, particularly in the lungs. These findings highlight the need for a multidisciplinary approach and the importance of systemic disease control in improving outcomes for this challenging patient population.
引用
- Salim HA, Msherghi A, Learned K, et al. Prognostic Factors in Thyroid Cancer Patients With Brain Metastases: A Systematic Review and Meta-Analysis. Thyroid. 2025. PMID: 40956665. doi:10.1177/10507256251372639
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。